140 related articles for article (PubMed ID: 24701029)
1. Preoperative gadoxetic Acid-enhanced MRI and simultaneous treatment of early hepatocellular carcinoma prolonged recurrence-free survival of progressed hepatocellular carcinoma patients after hepatic resection.
Matsuda M; Ichikawa T; Amemiya H; Maki A; Watanabe M; Kawaida H; Kono H; Sano K; Motosugi U; Fujii H
HPB Surg; 2014; 2014():641685. PubMed ID: 24701029
[TBL] [Abstract][Full Text] [Related]
2. Performance of gadoxetic acid MRI and diffusion-weighted imaging for the diagnosis of early recurrence of hepatocellular carcinoma.
Rimola J; Forner A; Sapena V; Llarch N; Darnell A; Díaz A; García-Criado A; Bianchi L; Vilana R; Díaz-González Á; Ayuso C; Bruix J; Reig M
Eur Radiol; 2020 Jan; 30(1):186-194. PubMed ID: 31372783
[TBL] [Abstract][Full Text] [Related]
3. Clinical value of gadoxetic acid-enhanced magnetic resonance imaging in surgery for hepatocellular carcinoma - with a special emphasis on early hepatocellular carcinoma.
Matsuda M
World J Hepatol; 2015 Dec; 7(30):2933-9. PubMed ID: 26730272
[TBL] [Abstract][Full Text] [Related]
4. Clinical Impact of Gadoxetic Acid-Enhanced Magnetic Resonance Imaging on Hepatoma Management: A Prospective Study.
Wang JH; Chen TY; Ou HY; Wang CC; Liu YW; Hung CH; Chen CH; Kuo CH; Hu TH; Cheng YF; Lu SN
Dig Dis Sci; 2016 Apr; 61(4):1197-205. PubMed ID: 26668057
[TBL] [Abstract][Full Text] [Related]
5. Prognostic performance of preoperative gadoxetic acid-enhanced MRI in resectable hepatocellular carcinoma.
Shim JH; Han S; Shin YM; Lee YJ; Lee SG; Kim KM; Lim YS; Lee HC
J Magn Reson Imaging; 2015 Apr; 41(4):1115-23. PubMed ID: 24841479
[TBL] [Abstract][Full Text] [Related]
6. Non-hypervascular hypointense nodules on Gd-EOB-DTPA-enhanced MRI as a predictor of outcomes for early-stage HCC.
Toyoda H; Kumada T; Tada T; Sone Y; Maeda A; Kaneoka Y
Hepatol Int; 2015 Jan; 9(1):84-92. PubMed ID: 25788383
[TBL] [Abstract][Full Text] [Related]
7. LI-RADS category 5 hepatocellular carcinoma: preoperative gadoxetic acid-enhanced MRI for early recurrence risk stratification after curative resection.
Wei H; Jiang H; Zheng T; Zhang Z; Yang C; Ye Z; Duan T; Song B
Eur Radiol; 2021 Apr; 31(4):2289-2302. PubMed ID: 33001306
[TBL] [Abstract][Full Text] [Related]
8. Peritumoral decreased uptake area of gadoxetic acid enhanced magnetic resonance imaging and tumor recurrence after surgical resection in hepatocellular carcinoma: A STROBE-compliant article.
Shin SK; Kim YS; Shim YS; Choi SJ; Park SH; Jung DH; Kwon OS; Choi DJ; Kim JH
Medicine (Baltimore); 2017 Aug; 96(33):e7761. PubMed ID: 28816953
[TBL] [Abstract][Full Text] [Related]
9. Non-hypervascular hypointense nodules detected by Gd-EOB-DTPA-enhanced MRI are a risk factor for recurrence of HCC after hepatectomy.
Toyoda H; Kumada T; Tada T; Niinomi T; Ito T; Sone Y; Kaneoka Y; Maeda A
J Hepatol; 2013 Jun; 58(6):1174-80. PubMed ID: 23376360
[TBL] [Abstract][Full Text] [Related]
10. Hepatocellular carcinoma detection in liver cirrhosis: diagnostic performance of contrast-enhanced CT vs. MRI with extracellular contrast vs. gadoxetic acid.
Semaan S; Vietti Violi N; Lewis S; Chatterji M; Song C; Besa C; Babb JS; Fiel MI; Schwartz M; Thung S; Sirlin CB; Taouli B
Eur Radiol; 2020 Feb; 30(2):1020-1030. PubMed ID: 31673837
[TBL] [Abstract][Full Text] [Related]
11. Non-Hypervascular Hypointense Hepatic Nodules during the Hepatobiliary Phase of Gadolinium-Ethoxybenzyl-Diethylenetriamine Pentaacetic Acid-Enhanced MRI as a Risk Factor of Intrahepatic Distant Recurrence after Radiofrequency Ablation of Hepatocellular Carcinoma.
Iwamoto T; Imai Y; Igura T; Kogita S; Sawai Y; Fukuda K; Yamaguchi Y; Matsumoto Y; Nakahara M; Morimoto O; Ohashi H; Fujita N; Kudo M; Takehara T
Dig Dis; 2017; 35(6):574-582. PubMed ID: 29040990
[TBL] [Abstract][Full Text] [Related]
12. Intra-individual comparison of hepatocellular carcinoma imaging features on contrast-enhanced computed tomography, gadopentetate dimeglumine-enhanced MRI, and gadoxetic acid-enhanced MRI.
Kim YN; Song JS; Moon WS; Hwang HP; Kim YK
Acta Radiol; 2018 Jun; 59(6):639-648. PubMed ID: 28825310
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of EOB-MRI for Hepatocellular Carcinoma in Japan.
Nishie A; Goshima S; Haradome H; Hatano E; Imai Y; Kudo M; Matsuda M; Motosugi U; Saitoh S; Yoshimitsu K; Crawford B; Kruger E; Ball G; Honda H
Clin Ther; 2017 Apr; 39(4):738-750.e4. PubMed ID: 28363694
[TBL] [Abstract][Full Text] [Related]
14. Gadoxetic acid disodium-enhanced magnetic resonance imaging outperformed multidetector computed tomography in diagnosing small hepatocellular carcinoma: A meta-analysis.
Liu X; Jiang H; Chen J; Zhou Y; Huang Z; Song B
Liver Transpl; 2017 Dec; 23(12):1505-1518. PubMed ID: 28886231
[TBL] [Abstract][Full Text] [Related]
15. Presence of non-hypervascular hypointense nodules on Gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging in patients with hepatocellular carcinoma.
Inoue M; Ogasawara S; Chiba T; Ooka Y; Wakamatsu T; Kobayashi K; Suzuki E; Tawada A; Yokosuka O
J Gastroenterol Hepatol; 2017 Apr; 32(4):908-915. PubMed ID: 27787908
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic performance of MRI using extracellular contrast agents versus gadoxetic acid for hepatocellular carcinoma: A systematic review and meta-analysis.
Feng Z; Zhao H; Guan S; Wang W; Rong P
Liver Int; 2021 May; 41(5):1117-1128. PubMed ID: 33647177
[TBL] [Abstract][Full Text] [Related]
17. Characteristics and Lenvatinib Treatment Response of Unresectable Hepatocellular Carcinoma with Iso-High Intensity in the Hepatobiliary Phase of EOB-MRI.
Kubo A; Suda G; Kimura M; Maehara O; Tokuchi Y; Kitagataya T; Ohara M; Yamada R; Shigesawa T; Suzuki K; Kawagishi N; Nakai M; Sho T; Natsuizaka M; Morikawa K; Ogawa K; Ohnishi S; Sakamoto N
Cancers (Basel); 2021 Jul; 13(14):. PubMed ID: 34298844
[TBL] [Abstract][Full Text] [Related]
18. Intra-individual comparison of gadolinium-enhanced MRI using pseudo-golden-angle radial acquisition with gadoxetic acid-enhanced MRI for diagnosis of HCCs using LI-RADS.
Kim YC; Min JH; Kim YK; Lee SJ; Ahn S; Kim E; Peeters H
Eur Radiol; 2019 Apr; 29(4):2058-2068. PubMed ID: 30324388
[TBL] [Abstract][Full Text] [Related]
19. Gd-EOB-DTPA-enhanced MRI is better than MDCT in decision making of curative treatment for hepatocellular carcinoma.
Yoo SH; Choi JY; Jang JW; Bae SH; Yoon SK; Kim DG; Yoo YK; Rha SE; Lee YJ; Jung ES
Ann Surg Oncol; 2013 Sep; 20(9):2893-900. PubMed ID: 23649931
[TBL] [Abstract][Full Text] [Related]
20. Gadoxetic acid (Gd-EOB-DTPA)-enhanced MRI versus gadobenate dimeglumine (Gd-BOPTA)-enhanced MRI for preoperatively detecting hepatocellular carcinoma: an initial experience.
Park Y; Kim SH; Kim SH; Jeon YH; Lee J; Kim MJ; Choi D; Lee WJ; Kim H; Koo JH; Lim HK
Korean J Radiol; 2010; 11(4):433-40. PubMed ID: 20592927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]